This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
the rate of treatment; the rate of treatment complications associated with expectant care; the rate of treatment complications associated with misoprostol treatment; and the numbers of outpatient follow-ups for misoprostol treatment and expectant treatment.
The numbers of patients requiring surgical intervention (or additional D&C if the primary treatment was surgical evacuation) were also derived from the literature.
Study designs and other criteria for inclusion in the review
The authors used the following selection criteria for inclusion in the review:
English language reports; trials including patients with miscarriage during the first 13 weeks of pregnancy with evidence of retained products of conception or with clinical diagnosis of incomplete miscarriage; treatment outcomes assessed within 14 days; paper reporting the number of patients requiring surgical intervention and the incidence of complications.
Eighteen studies were randomised clinical trials.
Sources searched to identify primary studies
MEDLINE was searched to identify primary studies.
Criteria used to ensure the validity of primary studies
Not reported.
Methods used to judge relevance and validity, and for extracting data
Number of primary studies included
Approximately 29 studies were reviewed.
Methods of combining primary studies
The primary studies were combined through pooled averages of complete abortion and complications for each treatment option. Patient acceptance rates of misoprostol treatment and expectant care were derived from the literature after adding weights dependent on the number of patients in each study.
Investigation of differences between primary studies
Differences between the primary studies were neither reported nor investigated.
Results of the review
The rate of patient acceptance of expectant care was 64% (range: 62 to 66). The rate of patient acceptance of misoprostol was 86% (range: 83 to 89).
The rate of complete abortion with expectant care was 75% (range: 25 to 99).
The rate of complete abortion with misoprostol was 69% (range: 50 to 95).
The rate of surgical complications was 6% (range: 0 to 11).
The rate of complications was 1.7% (range: 0.7 to 2.6) with expectant care and 2.5% (range: 1.5 to 3.5) with misoprostol.
The percentage of serious complications or need for additional surgical evacuations was 50% with surgical evacuation, 27% with expectant care, and 24% with misoprostol.
The percentage of less serious complications was 50% with surgery, 73% with expectant care, and 76% with misoprostol.
Measure of benefits used in the economic analysis
The authors did not use a summary benefit measure since the primary objective of the study was a cost analysis. Effectiveness data were embedded into the decision tree as probabilities in order to determine the cost of each strategy.
Direct costs
The costs were estimated from the perspective of a public health organisation in Hong Kong. The costs for hospital services were derived from the Hong Kong Gazette, which represents costs including labour costs. The cost of misoprostol was estimated by averaging drug acquisition costs. Discounting was not carried out, but it was not relevant since the costs were incurred during less than 2 years. The total costs of major cost items were reported, but details of the unit costs and quantities of resources used were not. The price year was not stated.
Statistical analysis of costs
The costs were treated deterministically.
Indirect Costs
The indirect costs were not included.
Currency
US dollars ($). The conversion rate from Hong Kong dollars (HKD) was $1 = HKD 7.8.
Sensitivity analysis
A one-way sensitivity analysis was used to determine whether the results of the model were sensitive to variations in the rates of complete abortion in the two forms of nonsurgical interventions. A two-way sensitivity analysis was also conducted, in which the rates of complete abortion using misoprostol treatment and expectant care were varied in order to determine the threshold line at which both groups had the same cost per patient. A decision tree analysis and Monte Carlo simulation were used for the probabilistic uncertainty analysis. All parameters were examined over high and low values or 95% confidence intervals (CIs). A sensitivity analysis was performed using TreeAge Pro 2005 software and Microsoft Excel 2000.
